Patient Capital Management LLC lessened its holdings in UBS Group AG (NYSE:UBS – Free Report) by 5.2% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,937,639 shares of the bank’s stock after selling 105,414 shares during the period. UBS Group makes up approximately 3.0% of Patient Capital Management LLC’s portfolio, making the stock its 12th largest position. Patient Capital Management LLC owned 0.06% of UBS Group worth $65,531,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Hsbc Holdings PLC increased its holdings in UBS Group by 10.2% during the 2nd quarter. Hsbc Holdings PLC now owns 1,720,276 shares of the bank’s stock worth $58,001,000 after purchasing an additional 159,219 shares during the period. Capital Fund Management S.A. purchased a new position in UBS Group in the second quarter worth approximately $1,256,000. Northwestern Mutual Wealth Management Co. lifted its stake in UBS Group by 16.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 63,304 shares of the bank’s stock worth $2,141,000 after acquiring an additional 8,894 shares during the last quarter. Fortress Financial Solutions LLC acquired a new position in UBS Group during the 2nd quarter worth approximately $221,000. Finally, Choreo LLC increased its position in shares of UBS Group by 24.6% in the 2nd quarter. Choreo LLC now owns 64,425 shares of the bank’s stock valued at $2,179,000 after purchasing an additional 12,737 shares during the last quarter.
UBS Group Price Performance
Shares of NYSE UBS opened at $38.09 on Friday. The stock has a market cap of $122.13 billion, a P/E ratio of 17.16, a P/E/G ratio of 0.66 and a beta of 1.20. UBS Group AG has a twelve month low of $25.75 and a twelve month high of $42.56. The stock has a 50 day moving average of $39.20 and a two-hundred day moving average of $37.16. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 3.77.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on UBS. Weiss Ratings reaffirmed a “buy (b)” rating on shares of UBS Group in a research report on Wednesday, October 8th. BNP Paribas downgraded UBS Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 4th. Morgan Stanley reaffirmed an “underweight” rating on shares of UBS Group in a research report on Monday. Keefe, Bruyette & Woods lowered UBS Group from a “hold” rating to a “moderate sell” rating in a research report on Friday, November 7th. Finally, Citigroup reiterated a “neutral” rating on shares of UBS Group in a research note on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.
View Our Latest Report on UBS Group
About UBS Group
UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. The company offers investment advice, estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions.
Read More
- Five stocks we like better than UBS Group
- How to Use the MarketBeat Stock Screener
- How Semtech’s Data Center Chips Are Powering the AI Boom
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Keysight Technologies’ Surge: The Market Wakes Up to This AI Play
- Energy and Oil Stocks Explained
- Is American Express the Credit Stock For a K-Shaped Economy?
Want to see what other hedge funds are holding UBS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UBS Group AG (NYSE:UBS – Free Report).
Receive News & Ratings for UBS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UBS Group and related companies with MarketBeat.com's FREE daily email newsletter.
